Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or β-blockers and the risk of atherosclerosis

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: To our knowledge, there are no prior studies which investigate whether there is a drug–gene interaction between the three genes involved in the renin–angiotensin system and ACE-inhibitor therapy or β-blocker therapy with these subclinical measurements of ath...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Schelleman, H, Klungel, O H, Witteman, J C M, Hofman, A, van Duijn, C M, de Boer, A, Stricker, B H CH
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2007
Teme:
Pharmacogenetics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2000614/
https://ncbi.nlm.nih.gov/pubmed/17298481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2007.02848.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items